No recent analyst price targets found for CUBT.
Latest News for CUBT
Curative Biotechnology Announces Canadian Patent Allowance
“Druggable Target to Treat Retinal Degeneration” Palm Beach Gardens, FL, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Curative Biotechnology, Inc. (OTC: CUBT) (“Curative” or the “Company”), a company developing metformin-based eye drops for the treatment of degenerative eye diseases, today announced that the Canadian Intellectual Property Office (CIPO) has issued a Notice of Allowance for Canadian Patent Application No.…
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for CUBT.
Senate Trading
No Senate trades found for CUBT.
U.S. House Trading
No House trades found for CUBT.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.